Corporate Fraud Hedge Funds Short selling

Episode #57: Gabriel Grego

Join TC and Georgia for Gabriel Grego’s return visit to The Chartcast where he discusses the accusations he’s made against Penumbra (NYSE: PEN) for releasing a fatally flawed medical device into the market, the company’s response, and what is next in his crusade against the company’s management team.

[Promo Tweet] | Check out Episode #30, our first interview with Gabriel!


(Coming soon!)